
Pharma Marketing Talk is hosted by John Mack, the creator of Pharma Marketing Blog and Publisher of Pharma Marketing News.
Subscribe
We accept advertising relevant to the interests of our members. For more information, see:
Media Kit
Operated by:
VirSci Corporation
PO Box 760
Newtown, PA 18940
215-504-4164
215-504-5739 (FAX)
E-mail: infovirsci@virsci.com
|

About Pharma Marketing Talk | List of Shows | Schedule and Archives | FAQs
The Importance of Downstream Channel Sales Data for Marketing
How to leverage this new source of daily sales data for competitive advantage
- Guest: Henry Olson, Edge Dynamics CEO
- Live Podcast Date: Tuesday, May 22, 2007, 1 PM Eastern US time
- Duration: Approx. 35 minutes
- Go to the Pharma Marketing Talk Channel Page to listen on the Web with your browser or click on a button below to listen to the streaming audio archive on your computer or to download the show for playback on your iPod or other portal audio player.
MP3 Audio File for your iPOD
WMA Audio File for Windows Media Player and other audio players
WAX Audio File for Windows Media Player
Background
A new source of detailed downstream channel sales data is available to Life Sciences manufacturers. Leading pharma manufacturers are leveraging this new source of daily sales data they already own for competitive advantage.
Through a series of in-depth qualitative interviews, Edge Dynamics, the leading provider of channel commerce management (CCM) solutions, has identified best practices with this new data source.
Edge Dynamics is also conducting a study of the importance and usage of this data amongst marketing and sales organizations (see and take the survey here). The best practice insights from the qualitative interviews, together with the online survey results, will be presented in this podcast.
Henry Olson Henry Olson is President and Chief Executive Officer and co-founder of Edge Dynamics. Previously, Mr. Olson served as Chief Products Officer. Prior to Edge Dynamics, he was Chief Architect at RedKlay, an enterprise software and services firm delivering e-business applications to manufacturing companies. Prior to RedKlay, Mr. Olson was Director of Product Development at Applicast, an application service provider delivering comprehensive enterprise application outsourcing to manufacturing companies. Before joining Applicast, Mr. Olson was lead architect on several large and innovative data warehousing, transaction management, and customer management applications in the financial services and insurance industries, at such firms as First Union (now Wachovia), Wells Fargo, Fidelity, and Mass Mutual. In addition to these engagements, Mr. Olson was Director of Product Development at Summit Data Group, an enterprise software and services firm delivering business applications to financial services and manufacturing companies.
Some topics to be discussed:
- How long does it take pharmaceutical companies to sense real or actual changes in customer demand?
- What are some of current techniques used to track these changes and what are there benefits? What are their limitations?
- What is downstream channel sales data, how does it differ from other Rx data, and how can it be put to use by pharmaceutical marketers?
Additional Resources
Survey: Sales Data Sources and Usage for Pharmaceutical Marketing and Sales
|